BK
Bahubali Kumar Borgave
About Bahubali Kumar Borgave
Data last updated:
Bahubali Kumar Borgave is a Director at Lysten Global Pharmaceuticals Private Limited (since 2016). The company operates in Pharma. Lysten Global Pharmaceuticals Private Limited reported revenue of ₹8,000 (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Lysten Global Pharmaceuticals Private Limited U24239PN2015PTC156013 | Director | 13 Jul 2016 | 2015 | ₹8,000 (FY 2023) | Active |
Board colleagues of Bahubali Kumar Borgave
| Name | DIN | Company | Designation |
|---|---|---|---|
| Nitin Parshram Jadhav | 07237608 | Lysten Global Pharmaceuticals Private Limited | Director |
| Sachin Lalasaheb Patil | 07243132 | Lysten Global Pharmaceuticals Private Limited | Director |
| Shilpa Nitin Jadhav | 07347378 | Lysten Global Pharmaceuticals Private Limited | Director |
| Vijay Shamrao Patil | 07334147 | Lysten Global Pharmaceuticals Private Limited | Director |
| Vikas Lalasaheb Patil | 07237588 | Lysten Global Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bahubali Kumar Borgave
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bahubali Kumar Borgave
Bahubali Kumar Borgave currently holds 1 directorship: Lysten Global Pharmaceuticals Private Limited (Director, since 13 Jul 2016, revenue ₹8,000 (FY 2023)).
Bahubali Kumar Borgave was first appointed on 13 Jul 2016 as Director at Lysten Global Pharmaceuticals Private Limited.
The current boards of Bahubali Kumar Borgave's companies include Nitin Parshram Jadhav (Lysten Global Pharmaceuticals Private Limited), Sachin Lalasaheb Patil (Lysten Global Pharmaceuticals Private Limited), Shilpa Nitin Jadhav (Lysten Global Pharmaceuticals Private Limited), Vijay Shamrao Patil (Lysten Global Pharmaceuticals Private Limited), Vikas Lalasaheb Patil (Lysten Global Pharmaceuticals Private Limited).